Market Closed -
Nyse
04:00:00 2024-05-31 pm EDT
|
5-day change
|
1st Jan Change
|
0.7057
USD
|
+3.60%
|
|
-3.01%
|
-1.58%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
194.8
|
187.5
|
168.1
|
139.8
|
56.42
|
58.45
|
-
|
-
|
Enterprise Value (EV)
1 |
181.4
|
187.5
|
168.1
|
139.8
|
56.42
|
47.25
|
72.35
|
72.15
|
P/E ratio
|
-11.6
x
|
-8.64
x
|
-6.16
x
|
-4.42
x
|
-1.43
x
|
-1.69
x
|
-2.23
x
|
-5.04
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
11,391
x
|
13,960
x
|
1,867
x
|
456
x
|
72.8
x
|
19.7
x
|
3.86
x
|
1.23
x
|
EV / Revenue
|
10,606
x
|
13,960
x
|
1,867
x
|
456
x
|
72.8
x
|
15.9
x
|
4.78
x
|
1.51
x
|
EV / EBITDA
|
-11.5
x
|
-9.13
x
|
-
|
-5.04
x
|
-1.73
x
|
-1.49
x
|
-2.79
x
|
-13.9
x
|
EV / FCF
|
-
|
-10.2
x
|
-7.7
x
|
-
|
-
|
-1.74
x
|
-2.89
x
|
240
x
|
FCF Yield
|
-
|
-9.82%
|
-13%
|
-
|
-
|
-57.4%
|
-34.6%
|
0.42%
|
Price to Book
|
13.7
x
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
41,092
|
48,198
|
53,536
|
57,521
|
78,686
|
82,824
|
-
|
-
|
Reference price
2 |
4.740
|
3.890
|
3.140
|
2.430
|
0.7170
|
0.7057
|
0.7057
|
0.7057
|
Announcement Date
|
2/20/20
|
3/22/21
|
3/30/22
|
3/15/23
|
3/25/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
0.0171
|
0.0134
|
0.09
|
0.3064
|
0.7753
|
2.967
|
15.15
|
47.64
|
EBITDA
1 |
-15.83
|
-20.53
|
-
|
-27.73
|
-32.55
|
-31.7
|
-25.9
|
-5.2
|
EBIT
1 |
-16.04
|
-21.25
|
-28.33
|
-31.78
|
-35.99
|
-33.37
|
-27.07
|
-11.3
|
Operating Margin
|
-93,818.25%
|
-158,211.62%
|
-31,467.21%
|
-10,372.42%
|
-4,641.78%
|
-1,124.72%
|
-178.7%
|
-23.72%
|
Earnings before Tax (EBT)
1 |
-16.1
|
-20.4
|
-26.99
|
-30.6
|
-35.68
|
-33.3
|
-27.3
|
-11.55
|
Net income
1 |
-16.1
|
-20.35
|
-26.81
|
-30.27
|
-35.32
|
-33.94
|
-28.3
|
-12.6
|
Net margin
|
-94,146.55%
|
-151,542.22%
|
-29,780.84%
|
-9,879.17%
|
-4,555.54%
|
-1,143.98%
|
-186.84%
|
-26.45%
|
EPS
2 |
-0.4100
|
-0.4500
|
-0.5100
|
-0.5500
|
-0.5000
|
-0.4167
|
-0.3167
|
-0.1400
|
Free Cash Flow
1 |
-
|
-18.41
|
-21.83
|
-
|
-
|
-27.1
|
-25.05
|
0.3
|
FCF margin
|
-
|
-137,046.17%
|
-24,241.98%
|
-
|
-
|
-913.48%
|
-165.38%
|
0.63%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/20/20
|
3/22/21
|
3/30/22
|
3/15/23
|
3/25/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
0.0142
|
0.1142
|
0.0398
|
0.0327
|
0.1197
|
0.1498
|
0.2163
|
0.1652
|
0.244
|
0.1715
|
0.53
|
0.8617
|
1.459
|
1.3
|
1.8
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-
|
-8.079
|
-
|
-7.819
|
-7.978
|
-7.71
|
-8.2
|
-8.2
|
-7.7
|
-
|
-
|
EBIT
1 |
-8.785
|
-7.677
|
-8.099
|
-7.993
|
-8.011
|
-9.045
|
-9.549
|
-8.653
|
-8.741
|
-8.384
|
-8.732
|
-8.619
|
-8.316
|
-6.4
|
-5.6
|
Operating Margin
|
-61,692.56%
|
-6,721.81%
|
-20,376.05%
|
-24,435.83%
|
-6,691.16%
|
-6,037.67%
|
-4,414.52%
|
-5,237.61%
|
-3,582.64%
|
-4,887.78%
|
-1,647.64%
|
-1,000.24%
|
-569.97%
|
-492.31%
|
-311.11%
|
Earnings before Tax (EBT)
1 |
-8.21
|
-7.718
|
-7.732
|
-7.812
|
-7.336
|
-8.873
|
-9.551
|
-8.453
|
-8.8
|
-8.472
|
-8.8
|
-8.767
|
-8.567
|
-6.4
|
-5.6
|
Net income
1 |
-7.933
|
-7.634
|
-7.65
|
-7.743
|
-7.242
|
-8.78
|
-9.471
|
-8.37
|
-8.698
|
-8.367
|
-8.857
|
-8.82
|
-8.519
|
-6.4
|
-5.6
|
Net margin
|
-55,710.04%
|
-6,684.2%
|
-19,244.53%
|
-23,671.57%
|
-6,049.2%
|
-5,860.46%
|
-4,378.43%
|
-5,066.46%
|
-3,565.29%
|
-4,877.81%
|
-1,671.22%
|
-1,023.59%
|
-583.9%
|
-492.31%
|
-311.11%
|
EPS
2 |
-0.1500
|
-0.1400
|
-0.1400
|
-0.1400
|
-0.1300
|
-0.1500
|
-0.1400
|
-0.1100
|
-0.1100
|
-0.1000
|
-0.1050
|
-0.1000
|
-0.0975
|
-0.0700
|
-0.0600
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/30/22
|
5/11/22
|
8/10/22
|
11/14/22
|
3/15/23
|
5/10/23
|
8/14/23
|
11/14/23
|
3/25/24
|
5/13/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
13.9
|
13.7
|
Net Cash position
1 |
13.4
|
-
|
-
|
-
|
-
|
11.2
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-0.5367
x
|
-2.635
x
|
Free Cash Flow
1 |
-
|
-18.4
|
-21.8
|
-
|
-
|
-27.1
|
-25.1
|
0.3
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
0.3500
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
0.51
|
1.94
|
0.97
|
-
|
-
|
0.83
|
1.73
|
3.3
|
Capex / Sales
|
2,989.88%
|
14,453.16%
|
1,081.25%
|
-
|
-
|
28.09%
|
11.44%
|
6.93%
|
Announcement Date
|
2/20/20
|
3/22/21
|
3/30/22
|
3/15/23
|
3/25/24
|
-
|
-
|
-
|
Last Close Price
0.7057
USD Average target price
3.633
USD Spread / Average Target +414.85% Consensus |
1st Jan change
|
Capi.
|
---|
| -1.58% | 58.45M | | -38.56% | 8.39B | | +0.18% | 3.32B | | +9.29% | 2.49B | | -18.21% | 2.06B | | -24.57% | 1.59B | | +32.37% | 1.15B | | -7.64% | 704M | | +8.42% | 678M | | -29.59% | 508M |
Bio Diagnostics & Testing
|